期刊文献+

慢性阻塞性肺疾病患者尿白三烯E4的变化 被引量:6

The change of urinary leukotriene E4 in patients with chronic obstructive pulmonary disease
下载PDF
导出
摘要 目的探讨慢性阻塞性肺疾病(COPD)患者尿白三烯E4(Ieukotriene E4 LTE4)的变化。方法采用竞争性酶联免疫吸附试验技术(ELISA)测定15位COPD患者急性加重期的尿LTE4水平,并与8位健康对照组者比较;同时对COPD患者的尿LTE4与其第一秒用力呼气容积(FEV1)、FEV1/用力肺活量(FVC)、外周血中性粒细胞(pNC)及外周血嗜酸性粒细胞计数(pEC)进行相关性分析。结果 COPD患者急性加重期尿LTE4明显高于健康对照组(P<0.01)。尿LTE4值和FEV1呈显著负相关(r=-0.607,P<0.01,n=23),和FEV1/FVC呈显著负相关(r=-0.697,P<0.01,n=23),和pNC无显著相关性(r=0.218,P>0.05),和pEC无显著相关性(r=-0.032,P>0.05)。结论 COPD患者急性加重期尿中LTE4增高。提示LTE4可能与COPD的发病机制有关。 Objective To evaluate the change of urinary leukotrience E4(LTE4) in patients with chronic obstructive pulmonary disease.Methods 15 patients with COPD were tested the urine concentration of LTE4 by ELISA in acute exacerbation,and compared to 8 healthy controls.In addition,the correlation between the urine concentration of LTE4 and forced expiratory volume in one second and forced expiratory volume in one second/forced vital capacity,periperal neutrophils,periperal eosinophil count of patients were investigated.Results Urinary LTE4 in exacerbations period was significantly higher than control group(857.85±393.05 vs 239.00±24.24 pg/ml,P〈0.01).There was a significant negative relation between urinary LTE4 and forced expiratary volume in one second(r=-0.607,P〈0.01,n=23).And a significant negative relation between urinary LTE4 and forced expiratary volume in one second/forced vital capacity(r=-0.697,P〈0.01,n=23).There was no correlation between urinary LTE4 and periperal neutrophils count(r=0.218,P〉0.05),and periperal eosinophil count(r=-0.365,P〉0.05).Conclusion Urinary LTE4 in patients with COPD was significantly higher than control group,which suggested that LTE4 participated in the pathogenesy.
出处 《临床肺科杂志》 2011年第7期987-988,共2页 Journal of Clinical Pulmonary Medicine
关键词 肺疾病 慢性阻塞性 尿白三烯E4 pulmonary disease chronic obstructive leukotriene E4
  • 相关文献

参考文献10

  • 1Lewis RA,Austen KF,Spberman RJ.Leukotriences and other product of the 5-lipoxygenase pathway.Biochemistry and relation to pathobiology in human disease[J].N Engl J Med,1990,323:645.
  • 2Samitas K,Chorianopoulos D,Vittorakis S.Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity[J].Respir Med,2009,103(5):750-756.
  • 3Kostikas K,Gaga M,Papatheodorou G.Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma[J].Chest,2005,127(5):1553.
  • 4Bleecker ER,Similarlities and differences in asthma:the Dutch hypothesis[J].Chest,2004,126(suppl):93S.
  • 5慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 6Mita H,Turikisawa N,Yamada T,Taniguchi M.Quantification of leukotriene B4 glucuronide in human urine[J].Prostaglandins Other Lipid Mediators,2007,83(1):42-49.
  • 7Smith CM,Hawksworth RJ,Thien FC.Urinary leukotriene E4 in bronchial asthma[J].Eur Respir J,1992,5(6):693-699.
  • 8Shindo K,Hiral Y,Fukumura M.Plasma levels of leukotriene E4 during clinical course of chronic obstructive pulmonary disease[J].ProstaglandinsLeukot Essent Fatty Acids,1997,56(3):213.
  • 9俞小卫,韦国桢,林亚媛,吴秀梅,周仪顺.慢性阻塞性肺疾病患者血清白三烯和α_1-抗胰蛋白酶的变化[J].南京医科大学学报(自然科学版),2004,24(2):182-184. 被引量:24
  • 10Cazzola M,Centanni S,Boveri B.Comparison of the bronchodilating effect of salmeterol and zafrlukast in combination with that of their use as single treatment in asthma and chronic obstructive pulmonary disease[J].Respiration,2001,68:452.

二级参考文献11

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Birke FW, Meade CJ, Anderskewitz R, et al, In vitro and in vivo pharmacological characterization of BIIL284, a novel and potent leukotriene B4 receptor antagonist[J]. J Pharmacol Exp Ther, 2001,297:458 - 466.
  • 3Shindo K, Hirai Y, Fukumura M, et al. Plasma levels of leukotriene E4 during clinical course of chronlc obstructive pulmonary dlsease[J]. Prostaglandins Leukot Essent Fatty Acids, 1997,56:213-217.
  • 4Crooks SW, Bayley DL, Hill SI, et al. Bronchial in flammation inacute bacterial exacerbations of chronic bronchitis: the role of leukotriene B4[J]. Eur Respir J, 2000,15:274 - 280.
  • 5GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 6Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
  • 7Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012.
  • 8冉丕鑫 王辰 姚婉贞 等.我国部分地区慢性阻塞性肺疾病流行病学研究[J].中华结核和呼吸杂志,2007,.
  • 9王辰,杜敏捷,曹大德,翁心植,吴小青,常青,王瑜.慢性肺原性心脏病急性发作期肺细小动脉血栓形成的病理观察[J].中华医学杂志,1997,77(2):123-125. 被引量:498
  • 10沈宁,姚婉贞,朱红,赵鸣武.慢性阻塞性肺疾病患者肺组织胆碱能M受体及其亚型的变化[J].中华结核和呼吸杂志,2001,24(4):212-214. 被引量:26

共引文献8246

同被引文献45

  • 1吕刚,韩笑,张秀娟,徐卫平,杜培革.半胱氨酰白三烯受体的研究进展[J].吉林医药学院学报,2008,29(3):164-167. 被引量:4
  • 2邱川,李明才,武燕,李敏.慢性阻塞性肺疾病气道炎症的研究进展[J].中国呼吸与危重监护杂志,2011,10(2):196-199. 被引量:58
  • 3吕晓东,丁韧烨,刘加良,符雁翔.支气管哮喘、慢性阻塞性肺疾病血清半胱氨酰白三烯测定及临床意义[J].浙江实用医学,2006,11(2):75-75. 被引量:6
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 5Miller M, Cho JY, Pham A, et al. Adiponectin and functional adi- ponectin receptor 1 are expressed by airway epithelial cells in chron- ic obstructive pulmonary disease [ J ]. J Immuno1,2009,182 ( 1 ) :684 - 691.
  • 6Rohde G, Wiethege A, Borg I, et al . Respiratory viruses in exac- erbations of chronic obstructive pulmonary disease requiring hospi- talisation: a case -control study[J]. Thorax, 2003,58 ( 1 ) :37.
  • 7Papadopoulos NG, Papi A, Meyer J ,et al. Rhinovirus infection up- regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells[ J]. Clin Exp Allergy,2001,31 : 1060.
  • 8Elias JA, Lee CG, Zheng T, et al. New insights into the pathogenesis of asthma[J].J Clin Invest, 2003,111(3): 291-297.
  • 9Rajanandh MG, Nageswari AD, llango K. Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study[J]. Clin 21~er, 2014, 36(4): 526-533.
  • 10Singh RK, Tandon R, Dastidar SG, et al. A review on leukotrienes and their receptors with reference to asthma[J]. J Asthma, 2013, 50(9): 922-931.

引证文献6

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部